CNAM
Campbell Newman Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
45,575
+3,019
| +7% | +$95.2K | 0.11% | 84 |
|
|
2025
Q1 | $1.39M | Sell |
42,556
-196
| -0.5% | -$6.42K | 0.12% | 80 |
|
|
2024
Q4 | $1.55M | Sell |
42,752
-164
| -0.4% | -$5.93K | 0.12% | 77 |
|
|
2024
Q3 | $1.34M | Sell |
42,916
-710
| -2% | -$22.1K | 0.1% | 85 |
|
|
2024
Q2 | $1.17M | Buy |
43,626
+91
| +0.2% | +$2.43K | 0.09% | 85 |
|
|
2024
Q1 | $1.48M | Buy |
43,535
+1,154
| +3% | +$39.4K | 0.12% | 75 |
|
|
2023
Q4 | $1.23M | Buy |
42,381
+26
| +0.1% | +$752 | 0.11% | 82 |
|
|
2023
Q3 | $1.17M | Buy |
42,355
+16,476
| +64% | +$454K | 0.11% | 83 |
|
|
2023
Q2 | $778K | Buy |
25,879
+564
| +2% | +$17K | 0.07% | 93 |
|
|
2023
Q1 | $917K | Buy |
25,315
+226
| +0.9% | +$8.19K | 0.09% | 88 |
|
|
2022
Q4 | $895K | Buy |
25,089
+791
| +3% | +$28.2K | 0.09% | 88 |
|
|
2022
Q3 | $822K | Buy |
24,298
+583
| +2% | +$19.7K | 0.09% | 84 |
|
|
2022
Q2 | $686K | Buy |
23,715
+1,019
| +4% | +$29.5K | 0.07% | 97 |
|
|
2022
Q1 | $734K | Buy |
22,696
+443
| +2% | +$14.3K | 0.07% | 96 |
|
|
2021
Q4 | $649K | Buy |
22,253
+584
| +3% | +$17K | 0.06% | 102 |
|
|
2021
Q3 | $578K | Buy |
21,669
+1,030
| +5% | +$27.5K | 0.06% | 103 |
|
|
2021
Q2 | $635K | Buy |
20,639
+1,127
| +6% | +$34.7K | 0.06% | 104 |
|
|
2021
Q1 | $511K | Buy |
19,512
+912
| +5% | +$23.9K | 0.05% | 109 |
|
|
2020
Q4 | $468K | Buy |
18,600
+1,381
| +8% | +$34.7K | 0.05% | 109 |
|
|
2020
Q3 | $359K | Buy |
17,219
+307
| +2% | +$6.4K | 0.05% | 112 |
|
|
2020
Q2 | $402K | Buy |
16,912
+148
| +0.9% | +$3.52K | 0.06% | 106 |
|
|
2020
Q1 | $302K | Sell |
16,764
-795
| -5% | -$14.3K | 0.05% | 107 |
|
|
2019
Q4 | $416K | Sell |
17,559
-25
| -0.1% | -$592 | 0.06% | 111 |
|
|
2019
Q3 | $483K | Sell |
17,584
-137
| -0.8% | -$3.76K | 0.07% | 106 |
|
|
2019
Q2 | $586K | Buy |
17,721
+1,154
| +7% | +$38.2K | 0.09% | 96 |
|
|
2019
Q1 | $581K | Buy |
16,567
+397
| +2% | +$13.9K | 0.09% | 96 |
|
|
2018
Q4 | $537K | Buy |
16,170
+1,669
| +12% | +$55.4K | 0.09% | 94 |
|
|
2018
Q3 | $730K | Buy |
14,501
+750
| +5% | +$37.8K | 0.11% | 82 |
|
|
2018
Q2 | $823K | Buy |
13,751
+633
| +5% | +$37.9K | 0.13% | 69 |
|
|
2018
Q1 | $601K | Buy |
13,118
+567
| +5% | +$26K | 0.1% | 90 |
|
|
2017
Q4 | $500K | Buy |
12,551
+2,301
| +22% | +$91.7K | 0.08% | 92 |
|
|
2017
Q3 | $410K | Buy |
10,250
+1,312
| +15% | +$52.5K | 0.07% | 93 |
|
|
2017
Q2 | $385K | Buy |
8,938
+413
| +5% | +$17.8K | 0.07% | 91 |
|
|
2017
Q1 | $267K | Buy |
+8,525
| New | +$267K | 0.05% | 102 |
|